Case Report: Abrocitinib treatment for refractory palmoplantar pustulosis
Xiaoyan Luo, Yaxin Huang, Mengdie Yang, Xia Xiong, Yongqiong Deng · 2026
Read Case Report: Abrocitinib treatment for refractory palmoplantar pustulosis by Xiaoyan Luo, Yaxin Huang, Mengdie Yang, Xia Xiong, Yongqiong Deng (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13623755.txt.
Description
Xiaoyan Luo and four co-authors report abrocitinib care for stubborn pustular disease of palms and soles. Their paper is from two thousand twenty-six. The ill brings sterile blisters back again and again, and standard drugs and biologics often fail or fade.
A woman with three years of the ill had short gains from steroids and a vitamin-A drug, then failed a mix of a pill, a cream, and light care. An immune biologic halves her scores but leaves live lesions and new itchy bumps, with blood marks of an allergy-style tilt. She swaps to abrocitinib. Scores crash near zero in weeks, the bumps clear, and blood marks settle. Control holds at four months with no ill effects.
Catalog record
| CREATOR | Xiaoyan Luo, Yaxin Huang, Mengdie Yang, Xia Xiong, Yongqiong Deng |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 22 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |